RPG Life Sciences Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1151.65
- Today's High:
- ₹1261.4
- Open Price:
- ₹1261.4
- 52W Low:
- ₹637.9255
- 52W High:
- ₹1251.3
- Prev. Close:
- ₹1261.4
- Volume:
- 9133
Company Statistics
- Market Cap.:
- ₹19.47 billion
- Book Value:
- 185.984
- Revenue TTM:
- ₹5.32 billion
- Operating Margin TTM:
- 17.33%
- Gross Profit TTM:
- ₹2.44 billion
- Profit Margin:
- 13.45%
- Return on Assets TTM:
- 14.42%
- Return on Equity TTM:
- 24.01%
Company Profile
RPG Life Sciences Limited had its IPO on under the ticker symbol RPGLIFE.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. RPG Life Sciences Limited has a staff strength of 1,214 employees.
Stock update
Shares of RPG Life Sciences Limited opened at ₹1261.4 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1151.65 - ₹1261.4, and closed at ₹1173.2.
This is a -6.99% slip from the previous day's closing price.
A total volume of 9,133 shares were traded at the close of the day’s session.
In the last one week, shares of RPG Life Sciences Limited have slipped by -3.76%.
RPG Life Sciences Limited's Key Ratios
RPG Life Sciences Limited has a market cap of ₹19.47 billion, indicating a price to book ratio of 5.166 and a price to sales ratio of 2.9909.
In the last 12-months RPG Life Sciences Limited’s revenue was ₹5.32 billion with a gross profit of ₹2.44 billion and an EBITDA of ₹1.06 billion. The EBITDA ratio measures RPG Life Sciences Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, RPG Life Sciences Limited’s operating margin was 17.33% while its return on assets stood at 14.42% with a return of equity of 24.01%.
In Q1, RPG Life Sciences Limited’s quarterly earnings growth was a positive 21.3% while revenue growth was a positive 14.6%.
RPG Life Sciences Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 29.1229
- PEG
Its diluted EPS in the last 12-months stands at ₹40.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into RPG Life Sciences Limited’s profitability.
RPG Life Sciences Limited stock is trading at a EV to sales ratio of 2.8142 and a EV to EBITDA ratio of 13.5788. Its price to sales ratio in the trailing 12-months stood at 2.9909.
RPG Life Sciences Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.98% and a payout ratio of 27.75%.
Balance sheet and cash flow metrics
- Total Assets
- ₹4.19 billion
- Total Liabilities
- ₹1.03 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 27.75%
RPG Life Sciences Limited ended 2024 with ₹4.19 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹4.19 billion while shareholder equity stood at ₹3.08 billion.
RPG Life Sciences Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.03 billion in other current liabilities, in common stock, ₹2.51 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹248.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
RPG Life Sciences Limited’s total current assets stands at ₹2.64 billion while long-term investments were ₹0 and short-term investments were ₹920.00 million. Its net receivables were ₹374.30 million compared to accounts payable of ₹646.90 million and inventory worth ₹950.50 million.
In 2024, RPG Life Sciences Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, RPG Life Sciences Limited paid ₹0.28 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1173.2
- 52-Week High
- ₹1251.3
- 52-Week Low
- ₹637.9255
- Analyst Target Price
- ₹
RPG Life Sciences Limited stock is currently trading at ₹1173.2 per share. It touched a 52-week high of ₹1251.3 and a 52-week low of ₹1251.3. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1099.42 and 200-day moving average was ₹884.27 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7062.2% of the company’s stock are held by insiders while 526.1% are held by institutions.
Frequently Asked Questions About RPG Life Sciences Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies. It operates in nephrology, rheumatology, oncology, gastroenterology, cardiovascular, orthopedics, respiratory, neurology, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology, pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.